Moderna shares posted one of their best gains in nearly two months as the vaccine developer said it advanced several pipeline candidates into late-stage clinical trials, including a next-generation Covid-19 vaccine. The drugmaker also announced up to $750 million in funding from Blackstone Life Sciences to help fund development for its flu program.
Alphabet shares surged to an all-time high after The Wall Street Journal reported Google is making more of its own semiconductors, preparing a new chip that can handle everything from YouTube advertising to big data analysis as the company tries to combat rising artificial-intelligence costs. The Technology Select Sector SPDR ETF ended up 0.5%.
Alphabet Hits New High Read Post »
By Mike Murphy Boeing denies allegations, says analysis found no safety concerns A whistleblower has reportedly complained to federal regulators that Boeing Co. overlooked safety concerns in the production of its 787 Dreamliner jets. The New York Times and Wall Street Journal reported Tuesday that the Federal Aviation Administration is investigating claims made by Sam Salehpour, a veteran Boeing engineer, who said the plane maker used shortcuts during the 787 assembly process that could critically strain fasteners in the planes’ fuselage. He claimed the strained joints could reduce the planes’ lifespan and potentially cause catastrophic damage. Boeing denied the allegations, and said it is “fully confident” in the 787 Dreamliner. “These claims about the structural integrity of the 787 are inaccurate and do not represent the comprehensive work Boeing has done to ensure the quality and long-term safety of the aircraft,” Boeing said in a statement. Boeing said the issues
Wells Fargo analyst Aaron Rakers maintains Intel (NASDAQ:INTC) with a Equal-Weight and lowers the price target from $48 to $43.
Wells Fargo analyst Aaron Rakers maintains Intel (NASDAQ:INTC) with a Equal-Weight Read Post »
Goldman Sachs analyst Mark Delaney maintains Tesla (NASDAQ:TSLA) with a Neutral and lowers the price target from $190 to $175.
Goldman Sachs analyst Mark Delaney maintains Tesla (NASDAQ:TSLA) with a Neutral Read Post »
Morgan Stanley analyst Meta Marshall reinstates Cisco Systems (NASDAQ:CSCO) with a Overweight and announces $58 price target.
By Adam Clark Nvidia was slipping early on Tuesday. The chip maker’s stock is down from recent highs and one analyst says a sharper fall is on the way. Nvidia shares were down 0.6% at $865.91 in premarket trading. The stock closed down 1.0% at $871.33 on Monday. The stock has dipped following an initial spike in the wake of the company’s GTC developers’ event when it unveiled its new range of Blackwell chips. It is now slightly lower than before the conference started. While consensus estimates call for demand for Nvidia’s graphics-processing units to power artificial-intelligence technology to be strong this year, the expectation is for growth to slow from 2025 onward. D.A. Davidson analyst Gil Luria has a Hold rating on Nvidia stock and a $620 target price, which is among the lowest by any Wall Street analyst. He argues that major AI chip customers such as Amazon.com
Nvidia Stock Is Stuttering. A Bear Makes the Case for a Steeper Fall. — Barrons.com Read Post »
Apple is facing one of the more difficult China demand environments Wedbush has seen in the last five years, but there are still a few reasons to be bullish, say analysts in a research note. The iPhone maker is contending with competitor Huawei gaining market share, geopolitical tensions that’s created a difficult selling environment, but Wedbush says current iPhone estimates for 2024 “remain hittable with 2025 Street estimates conservative.” The analysts also say the services business remains solid and artificial intelligence is “finally coming to Apple,” with a major AI announcement expected at the Apple Worldwide Developers Conference in June.
Apple’s China Headwinds Persist, But Reasons to Be Bullish Remain Read Post »
Morgan Stanley analyst Adam Jonas maintains Tesla (NASDAQ:TSLA) with a Overweight and maintains $310 price target.
Morgan Stanley analyst Adam Jonas maintains Tesla (NASDAQ:TSLA) with a Overweight Read Post »
Barclays analyst Kannan Venkateshwar maintains Netflix (NASDAQ:NFLX) with a Equal-Weight and raises the price target from $475 to $550.
Barclays analyst Kannan Venkateshwar maintains Netflix (NASDAQ:NFLX) with a Equal-Weight Read Post »
Pfizer (PFE) said Tuesday that its current pivotal phase 3 trial of Abrysvo against placebo in participants aged 18 to 59 years met primary endpoints. The patients were at an increased risk of developing respiratory syncytial virus-associated lower respiratory tract disease, the company said. In the trial, patients attained at least a four-fold increase in serum neutralizing titers for respiratory syncytial virus-A and respiratory syncytial virus-B after one month of Abrysvo as compared with pre-vaccination, according to the company. Pfizer also said Abrysvo was “well-tolerated” during the trial, while safety results were also “consistent” from prior Abrysvo studies. The company plans to share data with regulatory authorities for approval of Abrysvo in adults 18 to 59 years of age.
Amazon.com’s (AMZN) new “cost to serve” model highlights the potential for “significant upside” to base case estimates for the e-commerce giant, Morgan Stanley in a report emailed Monday. The new model shows “material upside to retail profit and gives us increased confidence” in the company’s ability to deliver more than $100 billion in earnings before interest and taxes in 2026, Morgan Stanley said. Morgan Stanley raised Amazon’s price target to $215 from $200 and kept the overweight rating. It also affirmed Amazon as a “top pick,” saying it’s “encouraged by the multiyear, efficiency based cash flow story.” “Our new breakdown of retail cost to serve (which includes shipping, fulfillment, payment processing, inbound shipping, returns, and inventory shrinkage costs) highlights how early it is in [Amazon’s] retail profitability improvement efforts,” the report said. Comments by Amazon’s management provided a “compass to follow and a path toward $10-$11 of ’26 FCF/share,” the